Updated consensus statement on biological agents for the treatment of rheumatoid arthritis and other rheumatic diseases (May 2002).
Furst
D E
DE
University of California, Los Angeles, CA, USA. defurst@mednet.ucla.edu
Breedveld
F C
FC
Kalden
J R
JR
Smolen
J S
JS
Antoni
C E
CE
Bijlsma
J W J
JW
Burmester
G R
GR
Cronstein
B
B
Keystone
E C
EC
Kavanaugh
A
A
Klareskog
L
L
D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000628:therapy; D006801:Humans; D007376:Interleukin-2 / Q000037:antagonists & inhibitors; D012216:Rheumatic Diseases / Q000628:therapy*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D007376:Interleukin-2; D014409:Tumor Necrosis Factor-alpha